These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37530190)

  • 1. [«Malignant stroma?» Alternative localization of classical genetic aberrations in neuroblastoma].
    Sharlai AS; Gegeliya NV; Druy AE; Konovalov DM
    Arkh Patol; 2023; 85(4):47-53. PubMed ID: 37530190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.
    Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R
    Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma in adolescents: genetic and clinical characterisation.
    Castel V; Villamón E; Cañete A; Navarro S; Ruiz A; Melero C; Herrero A; Yáñez Y; Noguera R
    Clin Transl Oncol; 2010 Jan; 12(1):49-54. PubMed ID: 20080471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Detection of Genetic Parameters for Prognostic Stratification of Neuroblastoma Using Multiplex Ligation-Dependent Probe Amplification Technique.
    Tumer S; Altungoz O; Bagci O; Olgun HN
    Genet Test Mol Biomarkers; 2016 Feb; 20(2):74-80. PubMed ID: 26790040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations.
    Mora J; Akram M; Cheung NK; Chen L; Gerald WL
    Med Pediatr Oncol; 2000 Dec; 35(6):534-7. PubMed ID: 11107110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK Gene Copy Number Gain and Immunohistochemical Expression Status Using Three Antibodies in Neuroblastoma.
    Kim EK; Kim S
    Pediatr Dev Pathol; 2017; 20(2):133-141. PubMed ID: 28326957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.
    Passariello A; De Brasi D; Defferrari R; Genesio R; Tufano M; Mazzocco K; Capasso M; Migliorati R; Martinsson T; Siani P; Nitsch L; Tonini GP
    Eur J Med Genet; 2013 Nov; 56(11):626-34. PubMed ID: 24035971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma.
    Lavarino C; Cheung NK; Garcia I; Domenech G; de Torres C; Alaminos M; Rios J; Gerald WL; Kushner B; LaQuaglia M; Mora J
    BMC Cancer; 2009 Feb; 9():44. PubMed ID: 19192278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
    Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
    Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of major genetic alterations in neuroblastoma.
    Costa RA; Seuánez HN
    Mol Biol Rep; 2018 Jun; 45(3):287-295. PubMed ID: 29455316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma.
    Kuick CH; Tan JY; Jasmine D; Sumanty T; Ng AYJ; Venkatesh B; Chen H; Loh E; Jain S; Seow WY; Ng EHQ; Lian DWQ; Soh SY; Chang KTE; Chen ZX; Loh AHP
    BMC Cancer; 2022 Jun; 22(1):717. PubMed ID: 35768791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.
    Villamón E; Piqueras M; Mackintosh C; Alonso J; de Alava E; Navarro S; Noguera R
    Virchows Arch; 2008 Jul; 453(1):47-55. PubMed ID: 18574593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
    Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
    J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group.
    Mazzocco K; Defferrari R; Sementa AR; Garaventa A; Longo L; De Mariano M; Esposito MR; Negri F; Ircolò D; Viscardi E; Luksch R; D'Angelo P; Prete A; Castellano A; Massirio P; Erminio G; Gigliotti AR; Tonini GP; Conte M
    Pediatr Blood Cancer; 2015 Oct; 62(10):1725-32. PubMed ID: 25925003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
    Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
    Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
    Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
    J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.